On the 28th of July 2020, in the Official Journal of French Republic (JORF), it was published an Order for the inclusion of the web application MOOVCARE POUMON intended for the medical telemonitoring of relapses and complications in patients with non-progressive lung cancer in the French List of Products and Healthcare Services Qualifying for Reimbursement (LPPR). The application is already included in the LPPR list in section 1, “Materials and treatments in the home, dietary products, items for dressings,” chapter 1, section 7, and a specific sub-section 7, which has been created for web applications and software for remote monitoring.
In 2019 the application MOOVCARE POUMON by Sivan was positively evaluated by the National Committee for the evaluation of medical devices and health technologies (CNEDIMTS) for inclusion into the LPPR for three years with Added Clinical Value (ASA) level III (moderate improvement) compared to the conventional care, monitoring by imaging and medical face to face consultations.
For now, a quarterly package for MOOVCARE POUMON is included in the LPPR with LPP code 1140921 and reimbursable tariff of €500.
See the details in French here.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.